GB0300805D0 - Compounds and their use - Google Patents

Compounds and their use

Info

Publication number
GB0300805D0
GB0300805D0 GBGB0300805.9A GB0300805A GB0300805D0 GB 0300805 D0 GB0300805 D0 GB 0300805D0 GB 0300805 A GB0300805 A GB 0300805A GB 0300805 D0 GB0300805 D0 GB 0300805D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0300805.9A
Other versions
GB2397301A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
De Novo Pharmaceuticals Ltd
Original Assignee
De Novo Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Novo Pharmaceuticals Ltd filed Critical De Novo Pharmaceuticals Ltd
Priority to GB0300805A priority Critical patent/GB2397301A/en
Publication of GB0300805D0 publication Critical patent/GB0300805D0/en
Publication of GB2397301A publication Critical patent/GB2397301A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
GB0300805A 2003-01-14 2003-01-14 Substituted 1,3,5-triazine derivatives Withdrawn GB2397301A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0300805A GB2397301A (en) 2003-01-14 2003-01-14 Substituted 1,3,5-triazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0300805A GB2397301A (en) 2003-01-14 2003-01-14 Substituted 1,3,5-triazine derivatives

Publications (2)

Publication Number Publication Date
GB0300805D0 true GB0300805D0 (en) 2003-02-12
GB2397301A GB2397301A (en) 2004-07-21

Family

ID=9951122

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0300805A Withdrawn GB2397301A (en) 2003-01-14 2003-01-14 Substituted 1,3,5-triazine derivatives

Country Status (1)

Country Link
GB (1) GB2397301A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1790345A1 (en) * 2005-11-02 2007-05-30 Esbatech AG Triazin beta-secretase inhibitors
WO2007051333A1 (en) * 2005-11-02 2007-05-10 Oncalis Ag Triazine beta-secretase inhibitors
WO2007071199A1 (en) * 2005-12-22 2007-06-28 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences 2,4-disubstituted amido-6-substituted-[1,3,5]triazine or 1,3-pyrimidine compounds, their processes for preparation, their pharmaceutical compositions and uses thereof
JP5485292B2 (en) * 2008-12-12 2014-05-07 ポクセル・エスアーエス Tetrahydrotriazine compounds for treating diseases associated with AMPK activity
WO2012012528A1 (en) * 2010-07-20 2012-01-26 Vestaron Corporation Insecticidal triazines and pyrimidines
CN104974142A (en) * 2015-06-12 2015-10-14 中国人民解放军第二军医大学 Substituted triaminotriazine secreting-type aspartic protease inhibitor and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH567484A5 (en) * 1973-04-05 1975-10-15 Sandoz Ag
WO1999036410A1 (en) * 1998-01-13 1999-07-22 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
IL139826A0 (en) * 1998-05-22 2002-02-10 Avanir Pharmaceuticals BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
AU5062100A (en) * 1999-06-14 2001-01-02 Novo Nordisk A/S Fviia/tf activity inhibiting compounds
US20020177007A1 (en) * 2001-05-25 2002-11-28 Boris Chernobrod Electroluminescent devices and method of manufacturing the same
EP1513522A2 (en) * 2002-01-18 2005-03-16 Sri International Methods of treating conditions associated with an edg receptor

Also Published As

Publication number Publication date
GB2397301A (en) 2004-07-21

Similar Documents

Publication Publication Date Title
GB0300804D0 (en) Compounds and their use
GB0300805D0 (en) Compounds and their use
GB0301143D0 (en) Compounds and their use
GB0317133D0 (en) Compounds and their use
GB0317283D0 (en) Compounds and their use
GB0314295D0 (en) Compounds and their use
GB0317281D0 (en) Compounds and their use
GB0316112D0 (en) Compounds and their use
GB0314292D0 (en) Compounds and their use
GB0314291D0 (en) Compounds and their use
GB0311821D0 (en) Compounds and their use
GB0311820D0 (en) Compounds and their use
GB0316113D0 (en) Compounds and their use
GB0310471D0 (en) Compounds and their use
GB0310470D0 (en) Compounds and their use
GB0310333D0 (en) Compounds and their use
GB0309320D0 (en) Compounds and their use
GB0309319D0 (en) Compounds and their use
GB0304820D0 (en) Compounds and their use
GB0321301D0 (en) Compounds and their use
GB0325620D0 (en) Compounds and their use
GB0326385D0 (en) Compounds and their use
GB0321442D0 (en) Compounds and their use
GB0322011D0 (en) Compounds and their use
GB0304819D0 (en) Compounds and their use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)